Mucus Relief Tablet
Product Images NDC 55910-739

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus Relief (NDC 55910-739). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dolgencorp, Inc. (dollar General & Rexall), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Guaifenesin 600 mg (Mucus Relief 600 mg Extended Release Caplets 1)

Mucus Relief 600 mg extended-release tablets by Dolgencorp, Inc. (Dollar General & Rexall), an oral expectorant with the active ingredient guaifenesin. The front panel highlights 12-hour relief, 20 tablets per package, and key benefits such as relieving chest congestion and thinning mucus. The side panel displays drug facts, active ingredient details, warnings, directions, inactive ingredients, and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.